T1	PERSONAL_INFORMATION 7 9	男性
T2	PERSONAL_INFORMATION 3 6	７０歳
T3	DRUG 64 76	Ｓ－１　＋　ＣＤＤＰ療法
T5	DRUG 98 107	デュルバルマブ療法
T6	DRUG 108 118	抗ＰＤ－Ｌ１抗体療法
T7	DRUG 142 150	抗ＰＤ－Ｌ１抗体
T8	DRUG 157 161	ＬＶＦＸ
T9	DRUG 542 550	抗ＰＤ－Ｌ１抗体
T10	DRUG 583 591	抗ＰＤ－Ｌ１抗体
T11	DRUG 783 791	抗ＰＤ－Ｌ１抗体
T12	DRUG 170 174	ＬＶＦＸ
T13	DRUG 595 608	免疫チェックポイント阻害薬
T14	DRUG 668 681	免疫チェックポイント阻害薬
T15	DRUG 853 861	抗ＰＤ－Ｌｌ抗体
T16	DRUG 396 399	抗生剤
T17	DRUG 409 412	抗生剤
T18	DISORDER 38 44	非小細胞肺癌
T19	DISORDER 127 129	発熱
T20	DISORDER 130 134	炎症反応
T21	DISORDER 183 188	肝機能障害
T22	DISORDER 189 193	炎症反応
T23	DISORDER 218 220	肺癌
T24	DISORDER 269 274	多発肝膿瘍
T25	DISORDER 277 279	肺癌
T26	DISORDER 280 285	多発肝転移
T27	DISORDER 310 314	凝固壊死
T28	DISORDER 319 324	肝細胞壊死
T29	DISORDER 333 335	肺癌
T30	DISORDER 256 259	小腫瘤
T31	DISORDER 381 383	炎症
T32	DISORDER 386 391	多発肝腫瘤
T33	DISORDER 424 428	炎症反応
T34	DISORDER 485 488	肝腫瘤
T35	DISORDER 506 509	肝腫瘤
T36	DISORDER 521 527	非小細胞肺癌
T37	DISORDER 562 570	壊死性多発肝腫瘤
T38	DISORDER 640 643	副作用
T39	DISORDER 705 708	肝障害
T40	DISORDER 737 740	壊死性
T41	DISORDER 799 807	壊死性多発肝腫瘤
T42	DISORDER 832 838	非小細胞肺癌
T43	DISORDER 873 881	壊死性多発肝腫瘤
T45	DISORDER 336 339	肝浸潤
T46	DISORDER 11 13	血疾
T47	DISORDER 458 463	多発肝腫瘤
A1	Negation T45 negated
T50	DISORDER 609 613	様々な癌
T51	TEST 25 27	ＣＴ
T52	TEST 28 34	気管支鏡検査
T53	TEST 205 209	造影ＣＴ
T54	TEST 481 483	ＣＴ
T55	TEST 500 502	ＣＴ
T56	TEST 289 294	肝腫瘍生検
T57	TEST 352 356	血液培養
T59	TEST 449 456	ＥＯＢ－ＭＲＩ
T60	DRUG 56 63	放射線化学療法
T61	OTHER 224 229	放射線治療
T62	DRUG 531 538	放射線化学療法
T63	DRUG 695 702	放射線化学療法
T64	DRUG 719 726	放射線化学療法
T65	DRUG 772 779	放射線化学療法
T66	DRUG 842 849	放射線化学療法
T67	OTHER 91 95	維持療法
T68	DISORDER 362 363	菌
T69	OPINION 194 199	更なる上昇
T70	TEST 180 182	採血
T72	OPINION 429 431	改善
T75	CHANGE_TRIGGER 78 80	導入
A2	Drug_Changes T3 started
T76	CHANGE_TRIGGER 164 166	開始
T77	ANATOMY 239 243	肝臓領域
T78	CHANGE_TRIGGER 412 416	投与開始
A4	Drug_Changes T17 started
T79	TIME 152 157	５日後から
T80	MEASURE 176 179	３口目
T83	TIME 418 424	１週間後には
T84	TIME 441 445	同時期に
T85	TIME 472 477	２ヶ月後に
T86	TIME 495 500	３ヶ月後の
T87	TIME 580 582	近年
T88	ANATOMY 734 736	肝臓
T89	OPINION 754 758	極めて稀
A5	Temporality T87 point
T90	OTHER 45 47	診断
T91	OPINION 134 136	上昇
T44	OPINION 489 491	減少
T48	OPINION 504 506;510 512	ほぼ 消失
A6	Negation T68 negated
T49	DISORDER 741 746	多発肝腫瘤
T73	OPINION 464 466	残存
A7	Sentiment T73 negative
A8	Sentiment T48 positive
T74	OPINION 648 657	十分判明していない
A9	Sentiment T74 neutral
T92	OPINION 905 909	興味深い
A10	Sentiment T92 neutral
T93	DISORDER 909 911	症例
A11	Sentiment T91 negative
A12	Sentiment T69 negative
A13	Sentiment T72 positive
A14	Sentiment T44 positive
A15	Sentiment T89 neutral
R1	HAS_RESULT Arg1:T51 Arg2:T18	
R2	HAS_RESULT Arg1:T52 Arg2:T18	
R3	SIGNALS_CHANGE_OF Arg1:T75 Arg2:T3	
R4	REFERS_TO Arg1:T60 Arg2:T3	
T4	TIME 83 87	２コース
R5	REFERS_TO Arg1:T5 Arg2:T6	
R6	REFERS_TO Arg1:T6 Arg2:T7	
A3	Drug_Changes T8 started
R7	SIGNALS_CHANGE_OF Arg1:T76 Arg2:T8	
R8	IS_OPINION_ABOUT Arg1:T91 Arg2:T20	
R9	TREATMENT_FOR Arg1:T8 Arg2:T19	
R10	TREATMENT_FOR Arg1:T8 Arg2:T20	
R11	HAS_DOSAGE Arg1:T12 Arg2:T80	
R12	IS_OPINION_ABOUT Arg1:T69 Arg2:T22	
R13	TREATMENT_FOR Arg1:T61 Arg2:T23	
R14	EXPERIENCED_IN Arg1:T30 Arg2:T77	
R15	HAS_RESULT Arg1:T53 Arg2:T30	
R16	MISC Arg1:T26 Arg2:T25	
R17	REFERS_TO Arg1:T27 Arg2:T28	
R18	HAS_RESULT Arg1:T56 Arg2:T28	
R19	HAS_RESULT Arg1:T56 Arg2:T45	
R20	HAS_RESULT Arg1:T57 Arg2:T68	
R21	IS_OPINION_ABOUT Arg1:T72 Arg2:T33	
R22	SIGNALS_CHANGE_OF Arg1:T78 Arg2:T17	
R23	IS_OPINION_ABOUT Arg1:T73 Arg2:T47	
R24	HAS_RESULT Arg1:T59 Arg2:T47	
R25	IS_OPINION_ABOUT Arg1:T44 Arg2:T34	
R26	IS_OPINION_ABOUT Arg1:T48 Arg2:T35	
R27	HAS_RESULT Arg1:T54 Arg2:T34	
R28	HAS_RESULT Arg1:T55 Arg2:T35	
R29	TREATMENT_FOR Arg1:T62 Arg2:T36	
R30	TREATMENT_FOR Arg1:T9 Arg2:T36	
R31	CAUSED Arg1:T9 Arg2:T37	
R32	INTERACTED_WITH Arg1:T62 Arg2:T9	
R33	INTERACTED_WITH Arg1:T65 Arg2:T11	
R34	CAUSED Arg1:T11 Arg2:T41	
R35	INTERACTED_WITH Arg1:T66 Arg2:T15	
R36	TREATMENT_FOR Arg1:T66 Arg2:T42	
R37	TREATMENT_FOR Arg1:T15 Arg2:T42	
R38	CAUSED Arg1:T15 Arg2:T43	
R39	IS_OPINION_ABOUT Arg1:T92 Arg2:T93	
R40	REFERS_TO Arg1:T93 Arg2:T43	
R41	REFERS_TO Arg1:T16 Arg2:T12	
R42	CAUSED Arg1:T16 Arg2:T33	
R43	EXAMINED_WITH Arg1:T26 Arg2:T56	
R44	EXAMINED_WITH Arg1:T24 Arg2:T56	
R45	EXAMINED_WITH Arg1:T46 Arg2:T51	
R46	EXAMINED_WITH Arg1:T46 Arg2:T52	
R47	TREATMENT_FOR Arg1:T60 Arg2:T18	
R48	REFERS_TO Arg1:T67 Arg2:T5	
R49	TREATMENT_FOR Arg1:T5 Arg2:T18	
R50	EXAMINED_WITH Arg1:T21 Arg2:T53	
R51	EXAMINED_WITH Arg1:T22 Arg2:T53	
R52	CAUSED Arg1:T31 Arg2:T32	
R53	TREATMENT_FOR Arg1:T16 Arg2:T31	
R54	REFERS_TO Arg1:T31 Arg2:T33	
R55	MISC Arg1:T29 Arg2:T45	
A16	Temporality T4 frequency
R56	REFERS_TO Arg1:T32 Arg2:T30	
R57	REFERS_TO Arg1:T34 Arg2:T47	
R58	REFERS_TO Arg1:T37 Arg2:T47	
T58	DISORDER 684 689	自己免疫的
R59	HAS_TIME Arg1:T3 Arg2:T4	
T71	TEST 663 667	病理組織
R60	HAS_RESULT Arg1:T70 Arg2:T21	
R61	HAS_RESULT Arg1:T70 Arg2:T22	
R62	HAS_RESULT Arg1:T71 Arg2:T39	
R63	CAUSED Arg1:T63 Arg2:T39	
R64	HAS_TIME Arg1:T8 Arg2:T79	
R65	HAS_TIME Arg1:T33 Arg2:T83	
R67	MISC Arg1:T17 Arg2:T85	
R68	MISC Arg1:T17 Arg2:T86	
R69	MISC Arg1:T7 Arg2:T79	
R66	MISC Arg1:T17 Arg2:T83	
R70	HAS_TIME Arg1:T34 Arg2:T85	
R71	HAS_TIME Arg1:T35 Arg2:T86	
R72	HAS_TIME Arg1:T47 Arg2:T84	
R73	MISC Arg1:T83 Arg2:T84	
